Nov 07, 2019 / 04:00AM GMT
Presentation
Nov 07, 2019 / 04:00AM GMT
=====================
Corporate Participants
=====================
* Kazuo Koshiji
Santen Pharmaceutical Co., Ltd. - Senior Corp. Officer of Corporate Administration, CFO and Head of Finance & Administration Division
* Naveed Shams
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Chief Scientific Officer and Head of Global Research & Development
* Satoshi Suzuki
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Head of Corporate Development Division & Head of China Business
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, COO, Head of North America Business & Director
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya
Santen Pharmaceutical Co Ltd
(OTCPK:SNPHY)
$
10.63
0.01 (0.09%)
Market Cap: 3.71 Bil
Enterprise Value: 3.70 Bil
PE Ratio: 21.47
PB Ratio: 1.99
GF Score: 76/100 Q2 2020 Santen Pharmaceutical Co Ltd Earnings Presentation Transcript
Nov 07, 2019 / 04:00AM GMT
Release Date Price:
$18.35
(+1.94%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot